Abstract
Mitral valve replacement after mitral stenosis is directly related to rheumatic fever, which is very common in our country. The development of PAH is the most frequent evolutionary course of MR. This is a retrospective study of 55 patients with severe PAH. The aim of our study is to demonstrate that severe pulmonary hypertension is not a contraindication to mitral valve replacement, and that long-term results are good.
Keywords:
Mitral stenosis, severe pulmonary arterial hypertension, mitral valve replacement, Algeria
Downloads
Download data is not yet available.
Most read articles by the same author(s)
- M. Abdelbaki, N. Khellafi, D. Benmessaoud, Pulmonary Embolism in a Patient with Behçet's Disease: A Case Report , International Journal of Innovative Research in Medical Science: Vol. 9 No. 01 (2024)
- M. Abdelbaki, A. Boureghda, N Hanifi, Comparative Research Between Sportsman's Heart and Hypertrophic Cardiomyopathy , International Journal of Innovative Research in Medical Science: Vol. 9 No. 01 (2024)
- M. Abdelbaki, Dr N. Khellafi, Pericardial Hydatidosis Revealed by Tamponade, A Case Report , International Journal of Innovative Research in Medical Science: Vol. 9 No. 01 (2024)
- M. Abdelbaki, M. Touati, Percutaneous Closure of Sinus of Valsalva Rupture into the Right Ventricule in a Pediatric Patient: A Case Report , International Journal of Innovative Research in Medical Science: Vol. 9 No. 01 (2024)
- Z. Bennoui, M. Abdelbaki, Atrial Fibrillation Revealing Chronic Constrictive Pericarditis , International Journal of Innovative Research in Medical Science: Vol. 9 No. 05 (2024)
How to Cite
Abdelbaki, M., H., B., & EH, B. (2024). Postoperative Results of Mitral Valve Replacement in Patients with Severe Pulmonary Arterial Hypertension (≥ 50mmhg). International Journal of Innovative Research in Medical Science, 9(01), 28–30. https://doi.org/10.23958/ijirms/vol09-i01/1805
Copyrights & License
Copyright © 2024 M. Abdelbaki Benalikhoudja H. Boudiaf EH this is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This work is licensed under a Creative Commons Attribution 4.0 International License.
